October 15, 2020 – The MITHRAS randomized clinical trial found that interventional...
Structural Heart Occluders
This channel includes news and new technology innovations about structural heart occluders. These include information of surgical repair and transcatheter closure of PFO, VSD, ASD and LAA. Devices include the Amplatzer and the Gore Helex
-
-
August 21, 2020 — According to a report published by Research Dive, the rising number of patients suffering from ...
-
August 6, 2020 – Conformal Medical Inc. announced it secured $85 million in Series C financing to support the company’s U.S.
-
News | Left Atrial Appendage (LAA) Occluders | October 16, 2020
October 16, 2020 — Positive clinical data from first-in-human studies of the Conformal Medical left atrial appendage...
An illustration showing the MitraClip catheter entering the left atrium through a transseptal puncture.
News | Heart Valve Technology | October 15, 2020
October 15, 2020 – The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial...
Boston Scientific recently introduced the newst iteration of LAA occluder device, the Watchman FLX. It uses small spikes to help better anchor the device and prevent embolization. Read more on this FDA approval.
News | Left Atrial Appendage (LAA) Occluders | August 21, 2020
August 21, 2020 — According to a report published by Research Dive, the rising number of patients suffering from atrial...
The Conformal Medical CLAAS device, a next-generation transcatheter left atrial appendage (LAA) closure occluder for patients with atrial fibrillation (AF). LAA occlusion allows AFib patients to go off of life-long anticoagulation therapy.
News | Left Atrial Appendage (LAA) Occluders | August 06, 2020
August 6, 2020 – Conformal Medical Inc. announced it secured $85 million in Series C financing to support the company’s...
Videos | Left Atrial Appendage (LAA) Occluders | July 24, 2020
Devi G. Nair, M.D., FHRS, director of cardiac electrophysiology, St. Bernards Heart and Vascular Center, Jonesboro, Ark...
News | Left Atrial Appendage (LAA) Occluders | July 22, 2020
July 22, 2020 — The U.S. Food and Drug Administration (FDA) has approved Boston Scientific's next generation Watchman...
News | Cardiovascular Clinical Studies | July 01, 2020
July 1, 2020 — Carag AG announced receiving U.S. Food and Drug Administration (FDA) Investigational Device Exemption (...
Videos | HRS | May 22, 2020
Interview with Andrew D. Krahn, M.D., FHRS, head of the division of cardiology at St. Paul’s Hospital, and professor of...
Videos | Structural Heart Occluders | March 24, 2020
Interview with Carey Kimmelstiel, M.D., FACP, FACC, director, cardiac catheterization laboratory, director,...
Videos | Structural Heart | February 27, 2020
Charles D. Resor, M.D., MSc, assistant director, cardiac catheterization lab, Tufts Medical Center and assistant...
News | Left Atrial Appendage (LAA) Occluders | February 03, 2020
February 3, 2020 — The U.S. Food and Drug Administration (FDA) has approved a the CATALYST trial designed to assess...
News | October 28, 2019
October 28, 2019 — The Gore Cardioform ASD Occluder received European CE mark clearance in early October. The device...
A MitraClip case underway at the University of Colorado Hospital hybrid cath lab. Left to right are doctors John Carroll, Edward Gill and Dominik Wiktor. (Photos by Dave Fornell)
Blog | University of Colorado Hospital | October 02, 2019
I recently had the opportunity to conduct an onsite visit to the University of Colorado Hospital Heart and Vascular...
News | Congenital Heart | September 20, 2019
September 20, 2019 – Abbott announced approvals in Europe for two of its pediatric devices — the Masters HP 15mm...
Technology | Structural Heart Occluders | June 10, 2019
June 10, 2019 – W. L. Gore & Associates (Gore) announced the U.S. Food and Drug Administration’s (FDA’s) premarket...
